Dextran 70
As of the edition of 20 October 2026, Dextran 70 is a drug: marketed, first approved in 1989 (CA).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1999
- Kind
- Unknown
- Brand name
- Tears Naturale II
- First approved
- 31 December 1989 (CA)
- Approvals on record
- 4 in 2 regions
- Holder of the most recent approval
- Alcon; 2 holders in all
- Registered trials
- 1, 1 stopped early
- Disease areas
- Digestive system; Infections
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 4 | 1 | 0 | 0 | 1 |
| All trials | 1 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Alcon | Applicant | 1989 to now |